Live Quote · NASDAQACCDHealthcare· Medical - Healthcare Information Services

Accolade, Inc.

$7.02 0.00%(+$0.00)
TickerSpark Score
76/100
Solid
80
Valuation
35
Profitability
90
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACCD research report →

52-Week Range60% of range
Low
$3.08
Current
$7.02
High
$9.67
Company Overviewwww.accolade.com

About the company

Accolade, Inc. , along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits.

CEO
Rajeev Singh
IPO
2020
Employees
2,400
HQ
Plymouth Meeting, PA, US

Price Chart

-24.43% · this period
$9.60$6.38$3.15Apr 08Oct 07Apr 08
Valuation
Market Cap
$575.59M
P/E
-5.27
P/S
1.39
P/B
1.18
EV/EBITDA
-9.11
Div Yield
0.00%
Profitability
Gross Margin
46.36%
Op Margin
-27.63%
Net Margin
-24.09%
ROE
-21.71%
ROIC
-16.65%
Growth & Income
Revenue
$414.29M · 14.09%
Net Income
$-99,805,000 · 78.29%
EPS
$-1.33 · 79.38%
Op Income
$-114,453,000
FCF YoY
40.23%
Performance & Tape
52W High
$9.67
52W Low
$3.08
50D MA
$6.95
200D MA
$4.78
Beta
2.10
Avg Volume
1.57M

Get TickerSpark's AI analysis on ACCD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 8, 25SINGH RAJEEVother175,000
Apr 8, 25SINGH RAJEEVother136,293
Apr 8, 25SINGH RAJEEVsell175,000
Apr 8, 25SINGH RAJEEVsell904,809
Apr 8, 25SINGH RAJEEVsell18,125
Apr 8, 25SINGH RAJEEVsell12,500
Apr 8, 25SINGH RAJEEVsell17,846
Apr 8, 25SINGH RAJEEVsell120,600
Apr 8, 25SINGH RAJEEVsell504,469
Apr 8, 25SINGH RAJEEVsell651,619
Coverage · ACCD

Our ACCD coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ACCD yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ACCD report →
Internal Compare

Similar companies

Peers in the same neighborhood.